Livzon Pharmaceutical Group (HK:1513) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Livzon Pharmaceutical Group has announced a proposed plan to repurchase a portion of its A Shares, aiming to boost investor confidence and enhance the long-term value of its shares. The company plans to use between RMB600 million and RMB1,000 million for this buyback, which will be executed through centralized bidding on the Shenzhen Stock Exchange. The repurchased shares will be canceled to reduce the company’s registered capital, potentially affecting up to 2.44% of its total share capital.
For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “…Overlook a Lack of Earnings Power”: UBS Analysts Target Intel Stock (NASDAQ:INTC), Stock Gains
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test
- “Direct Result of Your Feedback….” Microsoft Stock (NASDAQ:MSFT) Slips as The Option to Skip Updates Emerges